Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil-epirubicine-cyclophosphamide (FEC100) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000). [electronic resource] by
- Delbaldo, C
- Serin, D
- Mousseau, M
- Greget, S
- Audhuy, B
- Priou, F
- Berdah, J F
- Teissier, E
- Laplaige, P
- Zelek, L
- Quinaux, E
- Buyse, M
- Piedbois, P
Producer: 20140514
In:
European journal of cancer (Oxford, England : 1990) vol. 50
Availability: No items available.
|
|
5.
|
Postoperative irinotecan in resected stage II-III rectal cancer: final analysis of the French R98 Intergroup trial†. [electronic resource] by
- Delbaldo, C
- Ychou, M
- Zawadi, A
- Douillard, J Y
- André, T
- Guerin-Meyer, V
- Rougier, P
- Dupuis, O
- Faroux, R
- Jouhaud, A
- Quinaux, E
- Buyse, M
- Piedbois, P
Producer: 20160513
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 26
Availability: No items available.
|
|
6.
|
Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup Phase III BIG 02-98 Trial. [electronic resource] by
- Pestalozzi, B C
- Francis, P
- Quinaux, E
- Dolci, S
- Azambuja, E
- Gelber, R D
- Viale, G
- Balil, A
- Andersson, M
- Nordenskjöld, B
- Gnant, M
- Gutierrez, J
- Láng, I
- Crown, J P A
- Piccart-Gebhart, M
Producer: 20081104
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 19
Availability: No items available.
|
|
7.
|
Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. [electronic resource] by
- Lévy, E
- Piedbois, P
- Buyse, M
- Pignon, J P
- Rougier, P
- Ryan, L
- Hansen, R
- Zee, B
- Weinerman, B
- Pater, J
- Leichman, C
- Macdonald, J
- Benedetti, J
- Lokich, J
- Fryer, J
- Brufman, G
- Isacson, R
- Laplanche, A
- Quinaux, E
- Thirion, P
Producer: 19981130
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 16
Availability: No items available.
|
|
8.
|
Overall survival benefit for sequential doxorubicin-docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer--8-year results of the Breast International Group 02-98 phase III trial. [electronic resource] by
- Oakman, C
- Francis, P A
- Crown, J
- Quinaux, E
- Buyse, M
- De Azambuja, E
- Margeli Vila, M
- Andersson, M
- Nordenskjöld, B
- Jakesz, R
- Thürlimann, B
- Gutiérrez, J
- Harvey, V
- Punzalan, L
- Dell'orto, P
- Larsimont, D
- Steinberg, I
- Gelber, R D
- Piccart-Gebhart, M
- Viale, G
- Di Leo, A
Producer: 20131219
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 24
Availability: No items available.
|